Back to Search Start Over

Data from Polymorphisms in Inflammation Pathway Genes and Endometrial Cancer Risk

Authors :
Xiao-Ou Shu
Wei Zheng
Qiuyin Cai
Wei Lu
Wanqing Wen
Nurzhan Turmanov
Jone Trovik
Madeleine Corssen
Harvey Risch
Paul Pharoah
Rayna K. Matsuno
Tracy O'Mara
Galina Lurie
Lingeng Lu
Felicity Lose
Camilla Krakstad
Dylyara Kaydarova
Maggie Gorman
Kimberly Howarth
Alexander Hein
Mari K. Halle
Peter A. Fasching
Arif B. Ekici
Douglas Easton
Ingo B. Runnebaum
Alison Dunning
Natalia Dubrowinskaja
An Coosemans
Lieve Coenegrachts
Matthias W. Beckmann
Frederic Amant
Ping-Ping Bao
Helga B. Salvesen
Ying Zheng
Marc T. Goodman
Thilo Dörk
Diether Lambrechts
Herbert Yu
Ian Tomlinson
Deborah Thompson
Jirong Long
Alicia Beeghly-Fadiel
Amanda Spurdle
Yong-Bing Xiang
Ryan J. Delahanty
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Background: Experimental and epidemiologic evidence have suggested that chronic inflammation may play a critical role in endometrial carcinogenesis.Methods: To investigate this hypothesis, a two-stage study was carried out to evaluate single-nucleotide polymorphisms (SNP) in inflammatory pathway genes in association with endometrial cancer risk. In stage I, 64 candidate pathway genes were identified and 4,542 directly genotyped or imputed SNPs were analyzed among 832 endometrial cancer cases and 2,049 controls, using data from the Shanghai Endometrial Cancer Genetics Study. Linkage disequilibrium of stage I SNPs significantly associated with endometrial cancer (P < 0.05) indicated that the majority of associations could be linked to one of 24 distinct loci. One SNP from each of the 24 loci was then selected for follow-up genotyping. Of these, 21 SNPs were successfully designed and genotyped in stage II, which consisted of 10 additional studies including 6,604 endometrial cancer cases and 8,511 controls.Results: Five of the 21 SNPs had significant allelic odds ratios (ORs) and 95% confidence intervals (CI) as follows: FABP1, 0.92 (0.85–0.99); CXCL3, 1.16 (1.05–1.29); IL6, 1.08 (1.00–1.17); MSR1, 0.90 (0.82–0.98); and MMP9, 0.91 (0.87–0.97). Two of these polymorphisms were independently significant in the replication sample (rs352038 in CXCL3 and rs3918249 in MMP9). The association for the MMP9 polymorphism remained significant after Bonferroni correction and showed a significant association with endometrial cancer in both Asian- and European-ancestry samples.Conclusions: These findings lend support to the hypothesis that genetic polymorphisms in genes involved in the inflammatory pathway may contribute to genetic susceptibility to endometrial cancer.Impact statement: This study adds to the growing evidence that inflammation plays an important role in endometrial carcinogenesis. Cancer Epidemiol Biomarkers Prev; 22(2); 216–23. ©2012 AACR.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....ac81fc5a83a4edc1383b42b0c001382e